Extracellular vesicle-mediated gene therapy targets BRAFV600E-mutant colorectal cancer by inhibiting the MEK1/2-ERK1/2 pathway
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Engineered extracellular vesicles (EVs) loaded with BRAF V600E nucleic acid drugs specifically target and inhibit BRAF V600E colorectal cancer (CRC) cells. This novel gene therapy offers a promising treatment strategy for patients with this aggressive CRC subtype.
Area Of Science
- Oncology
- Gene Therapy
- Nanomedicine
Background
- Colorectal cancer (CRC) with BRAF V600E mutation presents a poor prognosis and limited treatment options.
- Standard chemotherapy is often ineffective against BRAF-mutant CRC, necessitating novel therapeutic strategies.
- Targeting the BRAF V600E mutation is crucial for improving survival rates in this CRC subtype.
Purpose Of The Study
- To develop a precise therapeutic system for BRAF V600E CRC using extracellular vesicles (EVs) and gene therapy.
- To investigate the efficacy and mechanism of EVs loaded with siBRAF V600E (EVs-siBRAF V600E) in preclinical models.
Main Methods
- Engineered cells were used to produce EVs loaded with siBRAF V600E.
- Therapeutic efficacy was evaluated in BRAF V600E-mutant and wild-type CRC cell lines and xenograft models.
- Patient-derived xenograft (PDX) models were utilized to assess therapeutic effects and mechanisms in a heterogeneous setting.
Main Results
- EVs-siBRAF V600E demonstrated specific inhibition of BRAF V600E CRC cells in vitro and in vivo.
- The therapeutic effect involves the regulation of the MEK1/2-ERK1/2 pathway.
- Excellent therapeutic efficacy was observed in PDX models, highlighting clinical relevance.
Conclusions
- Constructed therapeutic EVs are effective and specific for BRAF V600E-mutant CRC.
- This study presents a novel and targeted treatment strategy for BRAF V600E-mutant CRC.
- The findings offer a new avenue for improving outcomes in patients with this specific CRC subtype.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...